GEIST:UPC Searchengine

ORD_38807/2024

Abbott Diabetes Care Inc. v. Dexcom Deutschland GmbH, Dexcom International Limited , Dexcom Inc.

Date
2024-08-09
Division
Munich (DE) Local Division
Type of action
Application RoP262A
Language
EN

Metadata

Case IDORD_38807-2024-fc58da0881d6
Case number
Registry numberORD_38807/2024
Order referenceORD_38807/2024
Keywords
Headnotes

Documents and full text

Extractor: pypdf | Pages: 5

1 Procedural Order of the Court of First Instance of the Unified Patent Court Local Division Munich issued on 9 August 2024 CLAIMANT Abbott Diabetes Care Inc., 1360 South Loop Road, Alameda, CA 94502, USA, represented by CEO Robert Ford, at the same address, represented by: Attorneys-at-law Dr. Dietrich Kamlah, Dr. Christian Lederer, Dr. Gisbert Hohagen, Taylor Wessing Partnerschaftsgesellschaft mbB , Isartor 8, 80331 Munich, Germany, Patent Attorney Dr. Esslinger, Betten&Resch Partnerschaftsgesellschaft mbB, Maximilianplatz 14, 80333 Munich, Germany. DEFENDANTS 1. Dexcom Inc., 6340 Sequence Drive, CA 92121 San Diego, USA, rrepresented by CEO Kevin Sayer, at the same address, 2. Dexcom Deutschland GmbH, Haifa-Allee 2, 55128 Mainz, Germany, represented by the managing directors Michael Jon  ...